Cancer Research

Hidden Fat Linked to Artery Damage in Groundbreaking Study
Research & Development Hidden Fat Linked to Artery Damage in Groundbreaking Study

The startling reality that over 30% of adults may carry dangerous fat deposits deep within their abdomen or liver, even without visible signs of obesity, has sparked intense discussion in the medical community. This hidden fat, often undetectable through traditional measures like body mass index

Roche's Giredestrant Delays Breast Cancer Progression
Research & Development Roche's Giredestrant Delays Breast Cancer Progression

Today, we’re thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with a wealth of experience in research and development, particularly in the realm of innovative technologies in the pharmaceutical industry. With his deep understanding of cutting-edge treatments, Ivan is the perfect

How Do Stem Cells Drive Colorectal Cancer Growth?
Biotech & Bioprocessing How Do Stem Cells Drive Colorectal Cancer Growth?

Colorectal cancer (CRC) stands as a formidable global health challenge, ranking as the third most common cancer and the second leading cause of cancer-related deaths worldwide, according to GLOBOCAN 2020 data with a 10.0% incidence rate and a 9.4% mortality rate. Within the complex landscape of

Can Ozempic Interfere With Cancer Detection in Scans?
Tech & Innovation Can Ozempic Interfere With Cancer Detection in Scans?

In a startling revelation that has caught the attention of the medical community, a popular medication used for weight loss and diabetes management, Ozempic, may pose an unexpected challenge in the realm of diagnostic imaging. Known for its effectiveness in controlling blood sugar and aiding

DNA-Based Drug Sensor – Review
Research & Development DNA-Based Drug Sensor – Review

In the realm of modern healthcare, ensuring the right drug dosage for each patient remains a formidable challenge, with studies revealing that up to 50% of patients on critical therapies like chemotherapy receive suboptimal doses due to individual variations in drug metabolism. This discrepancy

Can Tecvayli Redefine Early Treatment for Multiple Myeloma?
Research & Development Can Tecvayli Redefine Early Treatment for Multiple Myeloma?

In the quiet corridors of cancer research, a seismic shift is stirring for those battling multiple myeloma, a blood cancer that relentlessly challenges both patients and clinicians, igniting hope for a breakthrough. Picture a patient, exhausted after rounds of treatment, hoping for a breakthrough

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later